Table 2.
Clinical features of the olfactory and gustatory dysfunction in patients who tested positive for SARS-CoV-2 infection.
| Variable (N = 134) | N (%) |
|---|---|
| OGD characteristics | |
| Sudden onset | 123 (91.8) |
| Fluctuant | 15 (11.2) |
| Olfactory disorder only | 6 (4.5) |
| Taste disorder only | 0 (0.0) |
| Combined perceptual disorder | 128 (95.5) |
| Anosmia and ageusia | 100 (74.6) |
| Anosmia and hypogeusia | 15 (11.2) |
| Hyposmia and ageusia | 1 (0.7) |
| Hyposmia and hypogeusia | 12 (9.0) |
| Other sinonasal signs and symptoms | 60 (44.8) |
| Nasal obstruction | 43 (32.1) |
| Rhinorrhea | 44 (32.8) |
| General signs and symptoms | 120 (89.5) |
| Fever (>37.5 °C/99.5 °F) | 89 (66.4) |
| Headache | 73 (54.5) |
| Asthenia | 51 (38.1) |
| Cough | 38 (28.4) |
| Nausea | 23 (17.2) |
| Myalgia | 17 (12.7) |
| Diarrhea | 5 (3.7) |
| Dyspnea | 3 (2.2) |
| Pharyngodynia | 2 (1.5) |
| Vertigo | 1 (0.8) |
| None | 14 (10.5) |
OGD, olfactory and gustatory dysfunction.